Ahmad Samir, Mai Elshinawi, Hesham Yehia, Mohamed Mahjouri, Mohamed Elhafy, Ahmed Shehata, Bassem Zarif, Azza Farrag
{"title":"Utility of residual SYNTAX score to predict clinical outcome after acute myocardial infarction","authors":"Ahmad Samir, Mai Elshinawi, Hesham Yehia, Mohamed Mahjouri, Mohamed Elhafy, Ahmed Shehata, Bassem Zarif, Azza Farrag","doi":"10.1093/eurheartjsupp/suad113.017","DOIUrl":null,"url":null,"abstract":"Abstract Aims Acute myocardial infarction (AMI) represents a huge health burden and a growing economical challenge, particularly with recurrent major adverse cardiovascular events (MACE). Large attention is critically mandated to identify population at higher risk for recurrent MACE to maximize secondary preventive measures. This study aimed to evaluate the utility of residual SYNTAX Score (RSS) after percutaneous coronary intervention (PCI) to the culprit vessel(s) in patients with AMI (STEMI or NSTEMI) to predict 6-months clinical outcomes. Methods and results A total of 492 eligible AMI patients were recruited through a period of 12 months. The RSS was systematically calculated after the PCI procedures. Median RSS was 4 (minimum 0–maximum 47.5). RSS showed excellent association to mid-term clinical outcomes. At cut-off value of RSS 3 had robust prediction for subsequent heart failure (HF), recurrent AMI, unplanned revascularization and the composite of MACE (P < 0.001). A significantly higher RSS was found in those who developed heart failure through the 6-months follow up period compared to those who did not (10 vs. 3, P < 0.001). Similar significant difference was found for recurrent ACS (11.5 vs. 3, P < 0.001), unplanned revascularization (15 vs. 3, P < 0.001) and occurrence of MACE (12 vs. 3, P < 0.001). Conclusions RSS is a sensitive predictor for 6-months adverse clinical outcomes after AMI. Calculating RSS at the end of PCI can guide intensification of secondary preventive measures. Ability of RSS- tailored management to impact clinical outcomes in high-risk patients is to be evaluated.Improvement, with subsequent amelioration of LV diastolic function. The Dapa group had a significantly greater improvement in LVEF at four months and six months compared to the Empa group. While the Empa group showed a significant improvement in HbA1C at six months compared to the Dapa group. Additional Content An author video to accompany this abstract is available on https://academic.oup.com/eurheartjsupp. Please click on the arrow next to ‘More Content’ and then click on ‘Author videos’.","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"41 1","pages":"0"},"PeriodicalIF":1.7000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal Supplements","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/eurheartjsupp/suad113.017","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract Aims Acute myocardial infarction (AMI) represents a huge health burden and a growing economical challenge, particularly with recurrent major adverse cardiovascular events (MACE). Large attention is critically mandated to identify population at higher risk for recurrent MACE to maximize secondary preventive measures. This study aimed to evaluate the utility of residual SYNTAX Score (RSS) after percutaneous coronary intervention (PCI) to the culprit vessel(s) in patients with AMI (STEMI or NSTEMI) to predict 6-months clinical outcomes. Methods and results A total of 492 eligible AMI patients were recruited through a period of 12 months. The RSS was systematically calculated after the PCI procedures. Median RSS was 4 (minimum 0–maximum 47.5). RSS showed excellent association to mid-term clinical outcomes. At cut-off value of RSS 3 had robust prediction for subsequent heart failure (HF), recurrent AMI, unplanned revascularization and the composite of MACE (P < 0.001). A significantly higher RSS was found in those who developed heart failure through the 6-months follow up period compared to those who did not (10 vs. 3, P < 0.001). Similar significant difference was found for recurrent ACS (11.5 vs. 3, P < 0.001), unplanned revascularization (15 vs. 3, P < 0.001) and occurrence of MACE (12 vs. 3, P < 0.001). Conclusions RSS is a sensitive predictor for 6-months adverse clinical outcomes after AMI. Calculating RSS at the end of PCI can guide intensification of secondary preventive measures. Ability of RSS- tailored management to impact clinical outcomes in high-risk patients is to be evaluated.Improvement, with subsequent amelioration of LV diastolic function. The Dapa group had a significantly greater improvement in LVEF at four months and six months compared to the Empa group. While the Empa group showed a significant improvement in HbA1C at six months compared to the Dapa group. Additional Content An author video to accompany this abstract is available on https://academic.oup.com/eurheartjsupp. Please click on the arrow next to ‘More Content’ and then click on ‘Author videos’.
摘要目的急性心肌梗死(AMI)是一个巨大的健康负担和日益增长的经济挑战,特别是复发性主要不良心血管事件(MACE)。必须高度重视确定复发性MACE风险较高的人群,以最大限度地采取二级预防措施。本研究旨在评估AMI (STEMI或NSTEMI)患者经皮冠状动脉介入治疗(PCI)后残留SYNTAX评分(RSS)对罪魁祸首血管的效用,以预测6个月的临床结果。方法和结果在12个月的时间里,共招募了492名符合条件的AMI患者。系统计算PCI术后的相对过饱和度。中位RSS为4(最小0 -最大47.5)。RSS与中期临床结果有很好的相关性。在截断值处,rss3对随后的心力衰竭(HF)、复发性AMI、计划外血运重建术和MACE复合有较强的预测作用(P <0.001)。在6个月的随访期间,发生心力衰竭的患者的相对过饱和度明显高于未发生心力衰竭的患者(10比3,P <0.001)。在复发性ACS中也发现了类似的显著差异(11.5 vs. 3, P <0.001),计划外血运重建术(15 vs. 3, P <0.001)和MACE的发生(12 vs. 3, P <0.001)。结论相对过饱和度是急性心肌梗死后6个月不良临床结局的敏感预测指标。在PCI结束时计算RSS可以指导二级预防措施的加强。在高危患者中,RSS量身定制的管理对临床结果影响的能力有待评估。改善,随后左室舒张功能改善。与Empa组相比,Dapa组在4个月和6个月时的LVEF有明显更大的改善。与Dapa组相比,Empa组在6个月时的HbA1C有显著改善。一个作者的视频,伴随着这个摘要可在https://academic.oup.com/eurheartjsupp。请点击“更多内容”旁边的箭头,然后点击“作者视频”。
期刊介绍:
The European Heart Journal Supplements (EHJs) is a long standing member of the ESC Journal Family that serves as a publication medium for supplemental issues of the flagship European Heart Journal. Traditionally EHJs published a broad range of articles from symposia to special issues on specific topics of interest.
The Editor-in-Chief, Professor Roberto Ferrari, together with his team of eminent Associate Editors: Professor Francisco Fernández-Avilés, Professors Jeroen Bax, Michael Böhm, Frank Ruschitzka, and Thomas Lüscher from the European Heart Journal, has implemented a change of focus for the journal. This entirely refreshed version of the European Heart Journal Supplements now bears the subtitle the Heart of the Matter to give recognition to the focus the journal now has.
The EHJs – the Heart of the Matter intends to offer a dedicated, scientific space for the ESC, Institutions, National and Affiliate Societies, Associations, Working Groups and Councils to disseminate their important successes globally.